Cannabidiol metabolism revisited: tentative identification of novel decarbonylated metabolites of cannabidiol formed by human liver microsomes and recombinant cytochrome P450 3A4

被引：11
|
作者：
Watanabe, Kazuhito [1 ]
Usami, Noriyuki [2 ]
Osada, Shigehiro [1 ]
Narimatsu, Shizuo [3 ]
Yamamoto, Ikuo [2 ]
Yoshimura, Hidetoshi [4 ]
机构：
[1] Daiichi Univ Pharm, Minami Ku, 22-1 Tamagawa Cho, Fukuoka, Fukuoka 8158511, Japan
[2] Hokuriku Univ, Fac Pharmaceut Sci, Ho 3 Kanagawa Machi, Kanazawa, Ishikawa 9201181, Japan
[3] Minami Kyushu Univ, Fac Hlth & Nutr, 5-1-2 Kirishima, Miyazaki 8800032, Japan
[4] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
来源：
FORENSIC TOXICOLOGY | 2019年 / 37卷 / 02期
关键词：
Cannabidiol; Decarbonylation; Metabolism; Human liver microsomes; CYP3A4; Cyclopentadienol; CARBON-MONOXIDE; EFFICACY; EPILEPSY;
D O I：
10.1007/s11419-019-00467-0
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
PurposeThe purpose of the present study was to identify the structures of cannabidiol (CBD) metabolites during CO formation by human liver microsomes and human recombinant cytochrome P450 (CYP) enzymes.MethodsCBD was NADPH-dependently metabolized by human liver microsomes and human recombinant CYP enzymes. Less-polar metabolites were analyzed by gas chromatography-mass spectrometry monitoring, and their estimated molecular ions were m/z 286, 358 and 481 after non-derivatization, trimethylsilylation and pentafluorobenzyl oxime formation, respectively.ResultsWe tentatively identified novel decarbonylated metabolites of CBD as keto-enol tautomers. Among eight major recombinant human CYP enzymes, only CYP3A4 catalyzed the formation of decarbonylated metabolites.ConclusionsCBD was biotransformed to two decarbonylated metabolites, an enol-form (cyclopentadienol structure), and a keto-form (cyclopentenone structure) by human liver microsomes and CYP3A4.
引用
收藏
页码：449 / 455
页数：7
相关论文
共 50 条
  • [31] Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
    Yamaori, Satoshi
    Ebisawa, Juri
    Okushima, Yoshimi
    Yamamoto, Ikuo
    Watanabe, Kazuhito
    LIFE SCIENCES, 2011, 88 (15-16) : 730 - 736
  • [32] Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA
    Jacobson, PA
    Green, K
    Birnbaum, A
    Remmel, RP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (06) : 461 - 467
  • [33] Potential of Lansoprazole as a Novel Probe for Cytochrome P450 3A Activity by Measuring Lansoprazole Sulfone in Human Liver Microsomes
    Yanagida, Yohei
    Watanabe, Minoru
    Takeba, Yuko
    Kumai, Toshio
    Matsumoto, Naoki
    Hayashi, Mikihito
    Suzuki, Satoshi
    Kinoshita, Yuichi
    Kobayashi, Shinichi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (08) : 1422 - 1426
  • [34] Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100
    N F Smith
    S D Baker
    F J Gonzalez
    J W Harris
    W D Figg
    A Sparreboom
    British Journal of Cancer, 2008, 98 : 1630 - 1632
  • [35] Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100
    Smith, N. F.
    Baker, S. D.
    Gonzalez, F. J.
    Harris, J. W.
    Figg, W. D.
    Sparreboom, A.
    BRITISH JOURNAL OF CANCER, 2008, 98 (10) : 1630 - 1632
  • [36] Stable expression of human cytochrome p450 3A4 in conjunction with human NADPH-cytochrome p450 oxidoreductase in V79 Chinese hamster cells
    Schneider, A
    Schmalix, WA
    Siruguri, V
    deGroene, EM
    Horbach, GJ
    Kleingeist, B
    Lang, D
    Bocker, R
    Belloc, C
    Beaune, P
    Greim, H
    Doehmer, J
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 332 (02) : 295 - 304
  • [37] In Vitro and in Vivo Inhibitory Effects of Glycyrrhetinic Acid in Mice and Human Cytochrome P450 3A4
    Lv, Qiao-Li
    Wang, Gui-Hua
    Chen, Shu-Hui
    Hu, Lei
    Zhang, Xue
    Ying, Guo
    Qin, Chong-Zhen
    Zhou, Hong-Hao
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2016, 13 (01):
  • [38] Inhibitory effect of salvianolate on human cytochrome P450 3A4 in vitro involving a noncompetitive manner
    Qin, Chong-Zhen
    Ren, Xian
    Zhou, Hong-Hao
    Mao, Xiao-Yuan
    Liu, Zhao-Qian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 15549 - 15555
  • [39] Pi-pi Stacking Mediated Cooperative Mechanism for Human Cytochrome P450 3A4
    Fa, Botao
    Cong, Shan
    Wang, Jingfang
    MOLECULES, 2015, 20 (05): : 7558 - 7573
  • [40] Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus
    Dostalek, Miroslav
    Court, Michael H.
    Yan, Bingfang
    Akhlaghi, Fatemeh
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (05) : 937 - 947
12345